1. Martinez-Beltran, J., Ledesma, M. A., Loza, E., Bonza, E., Baquero, F.: In vitro activity of the new cephalosporins HR 756, LY 127935 and cefoperazone (T-1551). Current Chemotherapy and Infectious Disease, proc. 11th ICC & the 19th ICAAC, Boston 1979, 91–93.
2. Rubio-Calvo, M. C., Gomez-Lus, R.:In vitro antibacterial activity of cefoperazone and LY 127935 against aerobic isolates. Current Chemotherapy and Infectious Disease, proc. 11th ICC & the 19th ICAAC, Boston 1979, 67–69.
3. Williams, R. J., Williams, J. D.: Activity of three cephalosporins and an oxa-beta-lactam compound againstPseudomonas aeruginosa. Current Chemotherapy and Infectious Disease, proc. 11th ICC & the 19th ICAAC, Boston 1979, 87–89.
4. Auckenthaler, R., Waldvogel, F. A. In vitro activity of a new semisynthetic cephalosporin: cefoperazone. Clin. Therap. 3, Special issue (1980) 89–97.
5. Jones, R. N., Fuchs, P. C., Barry, A. L., Gavan, T. L., Gerlach, E. H., Sommers, H. M. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates. Clin. Therap. 3, Special issue (1980) 14–23.